| |
|
|
| |
| 投稿时间： 2015-09-06 最后修改时间： 2015-12-02 摘要点击次数: 3827 全文下载次数: 1693 |
| |
| 引用本文：商金鑫, 郭志刚, 林其敏,等.北京市基本药物可及性评价研究[J].中国卫生政策研究,2016,9(2):52-58 |
|
| 商金鑫1, 郭志刚1, 林其敏1, 李玲2, 陈昌雄2, 冯岚2, 宋瑞霖2, 管晓东1,3, 史录文1,3 |
1. 北京大学药学院 北京 100191;
2. 中国医药创新促进会 北京 100020;
3. 北京大学医药管理国际研究中心 北京 100191 |
| 基金项目:国家自然科学基金青年科学基金项目(71303011);国家卫生计生委药政司委托项目 |
| |
|
| | 摘要:目的:从可获得性、价格水平和可负担性的角度评价北京市基本药物的可及性。方法:根据北京市2013年糖尿病领域社保抽样处方数据,并结合4家基层医疗卫生机构处方数据和实地调研,通过基本药物配备率、中位价格比(Median price rate,MPR)、致贫率等指标进行可及性评价。结果:21种样本药品中,尼群地平、硫酸镁、硝普钠、哌唑嗪、酚妥拉明和格列本脲6种药品的配备率不足15%;9个样本药品的MPR值为1.3~27.4;高血压、高血脂和糖尿病在城镇的致贫率为0.44%~0.70%,在农村的致贫率为1.17%~1.88%。结论:北京市部分基本药物配备率极低,基本药物价格水平偏高,基本药物的致贫人口数不容小视。建议:加强对基本药物可及性的监测,并出台相应配套政策。 | |
|
|
关键词:基本药物 可及性 可获得性 药品价格 可负担性
|
| |
| Analysis of accessibility of essential medicine in Beijing |
| SHANG Jin-xin1, GUO Zhi-gang1, LIN Qi-min1, LI Ling2, CHEN Chang-xiong2, FENG Lan2, SONG Rui-lin2, GUAN Xiao-dong1,3, SHI Lu-wen1,3 |
1. School of Pharmaceutical Sciences, Peking University, Beijing 100191, China;
2. China Pharmaceutical industry Research and Development Association, Beijing 100020, China;
3. International ResearchCenter of Medicinal Administration, Peking University, Beijing 100191, China |
| |
|
| | Abstract:Objectives:To evaluate essential medicines accessibility from the availability, drug price level and affordability perspective in Beijing. Methods:Data was collected from a sample of a Beijing social security database on diabetes in 2013 and a field research on 4 primary healthcare institutions. The essential medicine equipping rate, medium price ratio(MPR) and poverty-inducing effect were selected as accessibility indicators. Results:Among 21 sample drugs, the nitrendipine, magnesium sulfate, sodium nitroprusside, prazosin, phentolamine and glyburide equipping rates are less than 15%. The 9 sample drugs MPR varied from 1.3 to 27.4. The hypertension, hyperlipemia and diabete poverty-inducing rate varied from 0.44% to 0.70% in urban areas, and varied from 1.17% to 1.88% in rural areas. Conclusion:Some essential medicines in Beijing are equipped with a very low rate, but have a high price level, and the poverty-inducing population is large. We recommend strengthening the monitoring of essential medicines accessibility and introducing appropriate supporting policies. | |
|
|
|
|
